These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7824809)

  • 1. Efficacy and tolerance of a 12-week treatment with inhaled formoterol in patients with reversible obstructive lung disease.
    Stålenheim G; Wegener T; Grettve L; Lundbäck B; Melander B; Osterman K; Piitulainen E; Zetterström O
    Respiration; 1994; 61(6):305-9. PubMed ID: 7824809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trial.
    Condemi JJ
    Clin Ther; 2001 Sep; 23(9):1529-41. PubMed ID: 11589265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol.
    Steffensen I; Faurschou P; Riska H; Rostrup J; Wegener T
    Allergy; 1995 Aug; 50(8):657-63. PubMed ID: 7503401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of formoterol in elderly patients with reversible obstructive airways disease.
    Thomson NC; Angus R; Quebe-Fehling E; Brambilla R
    Respir Med; 1998 Mar; 92(3):562-7. PubMed ID: 9692123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.
    Wallin A; Melander B; Rosenhall L; Sandström T; Wåhlander L
    Thorax; 1990 Apr; 45(4):259-61. PubMed ID: 1972599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study].
    Lebecque P; Vliers S; De Saint-Moulin T; Godding V
    Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Formoterol as inhalation powder in the treatment of patients with reversible obstructive lung diseases. A 3-month placebo-controlled comparison of the effects of formoterol and salbutamol, followed by a 12-month period with formoterol alone].
    Steffensen IE; Faurschou P
    Ugeskr Laeger; 1996 Dec; 158(49):7092-6. PubMed ID: 8999618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formoterol, a new long-acting beta 2 agonist, inhaled twice daily, in stable asthmatic subjects.
    Midgren B; Melander B; Persson G
    Chest; 1992 Apr; 101(4):1019-22. PubMed ID: 1348219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of formoterol compared to salbutamol.
    Hekking PR; Maesen F; Greefhorst A; Prins J; Tan Y; Zweers P
    Lung; 1990; 168 Suppl():76-82. PubMed ID: 1974686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study.
    D'Urzo AD; De Salvo MC; Ramirez-Rivera A; Almeida J; Sichletidis L; Rapatz G; Kottakis J;
    Chest; 2001 May; 119(5):1347-56. PubMed ID: 11348938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.
    Kesten S; Chapman KR; Broder I; Cartier A; Hyland RH; Knight A; Malo JL; Mazza JA; Moote DW; Small P
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):622-5. PubMed ID: 1892303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between formoterol 12 microg b.i.d. and on-demand salbutamol in moderate persistent asthma.
    Molimard M; Bourcereau J; Le Gros V; Bourdeix I; Leynadier F; Duroux P;
    Respir Med; 2001 Jan; 95(1):64-70. PubMed ID: 11207020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthma.
    Bensch G; Berger WE; Blokhin BM; Socolovsky AL; Thomson MH; Till MD; Castellsague J; Della Cioppa G;
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):180-90. PubMed ID: 12197575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 6-month comparison between formoterol and salmeterol in patients with reversible obstructive airways disease.
    Vervloet D; Ekström T; Pela R; Duce Gracia F; Kopp C; Silvert BD; Quebe-Fehling E; Della Cioppa G; Di Benedetto G
    Respir Med; 1998 Jun; 92(6):836-42. PubMed ID: 9850367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol.
    Goldkorn A; Diotto P; Burgess C; Weatherall M; Holt S; Beasley R; Siebers R
    Respirology; 2004 Mar; 9(1):102-8. PubMed ID: 14982610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours.
    Maesen FP; Smeets JJ; Gubbelmans HL; Zweers PG
    Chest; 1990 Mar; 97(3):590-4. PubMed ID: 1968371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled formoterol during one year in asthma: a comparison with salbutamol.
    Arvidsson P; Larsson S; Löfdahl CG; Melander B; Svedmyr N; Wåhlander L
    Eur Respir J; 1991 Nov; 4(10):1168-73. PubMed ID: 1687129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.